Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment

Ivonne Suridjan1, Nathan Herrmann1, Alex Adibfar2

  • 1Hurvitz Brain Sciences Program, Sunnybrook Research Institute and Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Insights

Lower lipid peroxidation, a marker of oxidative stress, is linked to better cognitive gains from exercise in coronary artery disease patients at risk for dementia. Elevated levels may hinder exercise benefits.

Area of Science:

  • Biomarkers
  • Neuroscience
  • Cardiology

Background:

  • Coronary artery disease (CAD) patients are at increased risk for dementia.
  • Lipid peroxidation, a marker of oxidative stress, plays a role in vascular damage and cognitive decline.
  • Understanding the relationship between lipid peroxidation and cognitive function is crucial for developing interventions.

Purpose of the Study:

  • To investigate the association between lipid peroxidation markers and cognitive function in adults with CAD.
  • To examine how these markers influence cognitive response to a 24-week exercise intervention program.
  • To determine if lipid peroxidation can serve as a biomarker for early vascular cognitive impairment.

Main Methods:

  • Serum samples from 118 patients (29 with possible vascular mild cognitive impairment, 89 controls) were analyzed for lipid peroxidation products.
  • Ratios of early-stage (lipid hydroperoxides, LPH) to late-stage (8-isoprostane, 8-ISO; 4-hydroxy-2-nonenal, 4-HNE) products were calculated.
  • Cognitive performance was assessed before and after the 24-week exercise intervention.

Main Results:

  • A significant group effect on lipid peroxidation markers was observed after adjusting for covariates.
  • Lower baseline 8-isoprostane (8-ISO) concentration was associated with greater improvements in verbal memory and executive function.
  • Higher ratios of late-stage to early-stage lipid peroxidation products (8-ISO/LPH and (8-ISO+4-HNE)/LPH) correlated with less improvement in executive function post-intervention.

Conclusions:

  • Lipid peroxidation may serve as an early biomarker for vascular cognitive impairment in CAD patients.
  • Elevated lipid peroxidation levels might impede the cognitive benefits derived from exercise interventions in this population.
  • Targeting lipid peroxidation could be a strategy to enhance cognitive outcomes in individuals with CAD at risk for dementia.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
650
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
817
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
485
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
342
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
658